These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
238 related articles for article (PubMed ID: 11174874)
1. Hormone replacement therapy in clinical cardiology. Bittner V Cardiol Rev; 2000; 8(1):57-64. PubMed ID: 11174874 [TBL] [Abstract][Full Text] [Related]
2. Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). Grady D; Herrington D; Bittner V; Blumenthal R; Davidson M; Hlatky M; Hsia J; Hulley S; Herd A; Khan S; Newby LK; Waters D; Vittinghoff E; Wenger N; JAMA; 2002 Jul; 288(1):49-57. PubMed ID: 12090862 [TBL] [Abstract][Full Text] [Related]
3. Estrogen replacement therapy and the prevention of coronary heart disease in postmenopausal women. Contreras I; Parra D Am J Health Syst Pharm; 2000 Nov; 57(21):1963-8; quiz 1969-71. PubMed ID: 11094650 [TBL] [Abstract][Full Text] [Related]
4. Invited Commentary: Hormone therapy risks and benefits--The Women's Health Initiative findings and the postmenopausal estrogen timing hypothesis. Banks E; Canfell K Am J Epidemiol; 2009 Jul; 170(1):24-8. PubMed ID: 19468078 [TBL] [Abstract][Full Text] [Related]
5. Noncardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). Hulley S; Furberg C; Barrett-Connor E; Cauley J; Grady D; Haskell W; Knopp R; Lowery M; Satterfield S; Schrott H; Vittinghoff E; Hunninghake D; JAMA; 2002 Jul; 288(1):58-66. PubMed ID: 12090863 [TBL] [Abstract][Full Text] [Related]
6. Estrogen and progestin, lipoprotein(a), and the risk of recurrent coronary heart disease events after menopause. Shlipak MG; Simon JA; Vittinghoff E; Lin F; Barrett-Connor E; Knopp RH; Levy RI; Hulley SB JAMA; 2000 Apr; 283(14):1845-52. PubMed ID: 10770146 [TBL] [Abstract][Full Text] [Related]
7. Effect of estrogen plus progestin on risk for biliary tract surgery in postmenopausal women with coronary artery disease. The Heart and Estrogen/progestin Replacement Study. Simon JA; Hunninghake DB; Agarwal SK; Lin F; Cauley JA; Ireland CC; Pickar JH Ann Intern Med; 2001 Oct; 135(7):493-501. PubMed ID: 11578152 [TBL] [Abstract][Full Text] [Related]
8. Postmenopausal hormones and coronary artery disease: potential benefits and risks. Lobo RA Climacteric; 2007 Oct; 10 Suppl 2():21-6. PubMed ID: 17882668 [TBL] [Abstract][Full Text] [Related]
9. [Hormone replacement therapy of menopause, heart and blood vessels]. Kuttenn F; Gerson M Arch Mal Coeur Vaiss; 2001 Jul; 94(7):685-9. PubMed ID: 11494629 [TBL] [Abstract][Full Text] [Related]
10. The effect of estrogen plus progestin on knee symptoms and related disability in postmenopausal women: The Heart and Estrogen/Progestin Replacement Study, a randomized, double-blind, placebo-controlled trial. Nevitt MC; Felson DT; Williams EN; Grady D Arthritis Rheum; 2001 Apr; 44(4):811-8. PubMed ID: 11315920 [TBL] [Abstract][Full Text] [Related]
11. Hormone therapy and coronary heart disease: the role of time since menopause and age at hormone initiation. Grodstein F; Manson JE; Stampfer MJ J Womens Health (Larchmt); 2006; 15(1):35-44. PubMed ID: 16417416 [TBL] [Abstract][Full Text] [Related]
12. A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease. Grodstein F; Manson JE; Colditz GA; Willett WC; Speizer FE; Stampfer MJ Ann Intern Med; 2000 Dec; 133(12):933-41. PubMed ID: 11119394 [TBL] [Abstract][Full Text] [Related]
13. [Prevention of coronary heart disease by early postmenopausal hormone therapy: new supporting data]. Gaspard U J Gynecol Obstet Biol Reprod (Paris); 2008 Jun; 37(4):340-5. PubMed ID: 18249506 [TBL] [Abstract][Full Text] [Related]
15. Comparison of the Heart and Estrogen/Progestin Replacement Study (HERS) cohort with women with coronary disease from the National Health and Nutrition Examination Survey III (NHANES III). Herrington DM; Fong J; Sempos CT; Black DM; Schrott HG; Rautaharju P; Bachorik PS; Blumenthal R; Khan S; Wenger NK Am Heart J; 1998 Jul; 136(1):115-24. PubMed ID: 9665228 [TBL] [Abstract][Full Text] [Related]
16. Hormone replacement therapy (HRT) and ischaemic heart disease: getting to the heart of the matter. Chew S; Ng SC Singapore Med J; 2002 Jan; 43(1):41-4. PubMed ID: 12008777 [TBL] [Abstract][Full Text] [Related]
17. Hormones and heart disease in women: Heart and Estrogen/Progestin Replacement Study in perspective. Barrett-Connor E; Stuenkel C J Clin Endocrinol Metab; 1999 Jun; 84(6):1848-53. PubMed ID: 10372673 [TBL] [Abstract][Full Text] [Related]
19. Lipid changes on hormone therapy and coronary heart disease events in the Heart and Estrogen/progestin Replacement Study (HERS). Shlipak MG; Chaput LA; Vittinghoff E; Lin F; Bittner V; Knopp RH; Hulley SB; Am Heart J; 2003 Nov; 146(5):870-5. PubMed ID: 14597937 [TBL] [Abstract][Full Text] [Related]
20. Risk of cardiovascular disease in relation to the use of combined postmenopausal hormone therapy: detection bias and resolution of discrepant findings in two Women's Health Initiative studies. Shapiro S Climacteric; 2006 Dec; 9(6):416-20. PubMed ID: 17085373 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]